Clinical Genetics · 2006 · 18 citations · 15 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsMitochondrial GeneticsGenetic DisordersInborn Errors Of MetabolismMitochondrial DiseaseMitochondrial DisordersAllele FrequencyAllele SegregationFerrochelatase FunctionIncomplete PenetranceIron Metabolism GeneticsMitochondrial Enzyme DeficienciesMitochondrial Heme SynthesisMutation
Erythropoietic protoporphyria (EPP) is an autosomal dominant disease with incomplete penetrance due to reduced activity of ferrochelatase (FECH), a mitochondrial enzyme that catalyzes the final step of the heme biosynthetic pathway. The clinical phenotype of EPP results from co-inheritance of a mutated allele and a wild-type low-expressed allele of the FECH gene. To date, more than 88 different mutations have been identified in the FECH gene of patients with EPP. There are evidences suggesting that an entire haplotype (-251G, IVS1-23T and IVS3-48C) reduces allele expression. In this study, we searched for the -251A/G, IVS1-23C/T and IVS3-48T/C polymorphisms in two unrelated Italian families with EPP. In all the patients, carrying the -250G>C mutation in the promoter region, the IVS3-48C on the other allele showed apparent homozygosity and absence of Mendelian segregation. By RNA and long polymerase chain reaction analysis, we identified a deletion of 5576 bp (g12490_18067), including exons 3 and 4, in cis with the -250G>C mutation in the promoter.
15
Dynamics of GATA transcription factor expression during erythroid differentiation
Martin O. Leonard, M Brice, JD Engel et al. · Blood · 1993 · 245 citations · Full text
Structure of the human ferrochelatase gene
Shigeru Taketani, Johji Inazawa, Yoshitsugu Nakahashi et al. · European Journal of Biochemistry · 1992 · 164 citations · Full text